Cellebrite (CLBT)
Nasdaq Market Closed
Cellebrite DI Ltd. is a digital intelligence company that develops software and investigative technology for public-sector agencies and enterprise customers. Its tools help authorized users collect, preserve, decode, review, and analyze digital evidence from mobile phones, computers, cloud sources, applications, and other connected devices. The company is particularly associated with mobile device forensics, where investigators need to extract and interpret large volumes of data while maintaining evidentiary integrity.
Cellebrite serves law enforcement, defense, intelligence, border security, and other government organizations that use digital evidence in criminal investigations, counterterrorism work, cyber operations, and intelligence analysis. Its products are designed to make fragmented digital data searchable and actionable, supporting tasks such as case management, analytics, evidence sharing, and investigative workflow automation.
The company also sells to corporations, service providers, and legal teams. In the private sector, Cellebrite’s technology can support internal investigations, eDiscovery, incident response, compliance reviews, and mobile application security validation. This gives the company exposure to both public safety budgets and corporate demand for digital investigation capabilities.
Cellebrite operates internationally across the Americas, Europe, the Middle East, Africa, and Asia-Pacific, with the Americas an important revenue region. For investors, CLBT offers exposure to the expanding need for digital forensics and data-driven investigations. Its performance depends on software adoption, subscription renewals, public-sector procurement cycles, product credibility, and the company’s ability to address evolving devices, encryption, cloud services, and legal requirements.
Last updated
- Market Cap
- —
- P/E
- —
- P/FCF
- —
- P/S
- —
- Enterprise Value
- —
- Sector
- —
- Industry
- —
- Address
- —
Digital Evidence Management Market to Surpass USD 19.25B by 2032 Driven by Tech Advancements & Cybercrime | Research by SNS Insider
Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors
Cellebrite ernennt die renommierte Cybersecurity-Expertin Sigalit Shavit zum Chief Information Officer
Cellebrite nomme Sigalit Shavit, experte renommée en cybersécurité, au poste de DSI
2X Welcomes Lisa Cole as the Company's First CMO, Igniting AI Innovation and Accelerating Growth - GlobeNewswire
Cellebrite Announces Availability of Industry-Leading Endpoint Inspector SaaS Solution on Amazon Web Services Marketplace
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates
Arbe Robotics Ltd. (ARBE) Reports Q1 Loss, Lags Revenue Estimates
FUTU vs. CLBT: Which Stock Should Value Investors Buy Now?
Cellebrite Announces Participation in Upcoming Investor Conferences
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
Are Business Services Stocks Lagging Cellebrite DI Ltd. (CLBT) This Year?
Will Cellebrite DI Ltd. (CLBT) Beat Estimates Again in Its Next Earnings Report?
Cellebrite to Report First-Quarter 2024 Financial Results on May 23, 2024
Reasons to Add Maximus (MMS) Stock to Your Portfolio Now
Reasons to Retain Omnicom (OMC) Stock in Your Portfolio Now
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
Cellebrite revolutioniert die Datenerfassung mit bahnbrechender SaaS-Lösung als integralem Bestandteil der Case-to-Closure-Plattform des Unternehmens
Cellebrite révolutionne la collecte de données avec une solution SaaS révolutionnaire faisant partie intégrante de la plateforme Case-to-Closure de l’entreprise
Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership
Income Statement
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2021 Q4 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| EBITDA | 0 | 0 | 0 | 0 | 0 |
| Net income | — | — | — | — | — |
| Basic EPS | — | — | — | — | — |
| Diluted EPS | — | — | — | — | — |
Balance Sheet
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2021 Q4 |
|---|---|---|---|---|---|
| Total assets | 938.85M | 690.57M | 532.89M | 403.29M | 339.78M |
| Total liabilities | 454.53M | 354.55M | 498.67M | 329.43M | 413.13M |
| Total equity | 484.32M | 336.02M | 34.21M | 73.87M | -73.35M |
| Cash & equivalents | 124.46M | 191.66M | 189.52M | 87.65M | 145.97M |
| Current assets | 575.85M | 567.59M | 422.08M | 295.93M | 273.21M |
| Current liabilities | 369.66M | 295.5M | 253.82M | 207.78M | 186.57M |
Cash Flow
| Line Item | 2025 Q4 | 2024 Q4 | 2023 Q4 | 2022 Q4 | 2021 Q4 |
|---|---|---|---|---|---|
| Operating cash flow | — | — | — | — | — |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Change in cash | — | — | — | — | — |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 144 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 4 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 144 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 144 — Cellebrite DI Ltd. | View Filing | |
| form 4 | Form 4 — GEE DAVID NICHOLAS | View Filing | |
| form 4 | Form 4 — GEE DAVID NICHOLAS | View Filing | |
| edgar index | 4 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 144 — Cellebrite DI Ltd. | View Filing | |
| form 4 | Form 4 — Jewell Marcus | View Filing | |
| edgar index | 6-K — Cellebrite DI Ltd. | View Filing | |
| edgar index | 4 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 4 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 4 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 144 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 144 — Cellebrite DI Ltd. | View Filing | |
| form 4 | Form 4 — Ramji Shiven | View Filing | |
| form 4 | Form 4 — Jewell Marcus | View Filing | |
| form 4 | Form 4 — GEE DAVID NICHOLAS | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 3 — Cellebrite DI Ltd. | View Filing | |
| form 3 | Form 3 — CLAMMER ADAM | View Filing | |
| form 3 | Form 3 — CLAMMER ADAM | View Filing | |
| form 3 | Form 3 — CLAMMER ADAM | View Filing | |
| form 3 | Form 3 — CLAMMER ADAM | View Filing | |
| form 3 | Form 3 — Van Buren Brandon | View Filing | |
| form 3 | Form 3 — Wade Christopher Michael | View Filing | |
| form 3 | Form 3 — Gruber Dafna | View Filing | |
| form 3 | Form 3 — Barter David | View Filing | |
| form 3 | Form 3 — GEE DAVID NICHOLAS | View Filing | |
| form 3 | Form 3 — GEE DAVID NICHOLAS | View Filing | |
| form 3 | Form 3 — Windham Holly B. | View Filing | |
| form 3 | Form 3 — Jewell Marcus | View Filing | |
| form 3 | Form 3 — Jewell Marcus | View Filing | |
| form 3 | Form 3 — CAPELLAS MICHAEL D | View Filing | |
| form 3 | Form 3 — Baudot-Trajtenberg Nadine | View Filing | |
| form 3 | Form 3 — Armon Ronnen | View Filing | |
| form 3 | Form 3 — Armon Ronnen | View Filing | |
| form 3 | Form 3 — Armon Ronnen | View Filing | |
| form 3 | Form 3 — Armon Ronnen | View Filing | |
| form 3 | Form 3 — Armon Ronnen | View Filing | |
| form 3 | Form 3 — Shavit Sigalit | View Filing | |
| form 3 | Form 3 — Shavit Sigalit | View Filing | |
| form 3 | Form 3 — Hogan Thomas E. | View Filing | |
| form 3 | Form 3 — Hogan Thomas E. | View Filing | |
| form 3 | Form 3 — Hogan Thomas E. | View Filing | |
| form 3 | Form 3 — Richardson Troy | View Filing | |
| form 3 | Form 3 — Tadmor-Eilat Zohar | View Filing | |
| form 3 | Form 3 — Tadmor-Eilat Zohar | View Filing | |
| form 3 | Form 3 — Tadmor-Eilat Zohar | View Filing | |
| form 3 | Form 3 — Utsumi Ryusuke | View Filing | |
| form 3 | Form 3 — Utsumi Ryusuke | View Filing | |
| form 3 | Form 3 — Domnitz Yonatan | View Filing | |
| form 3 | Form 3 — Domnitz Yonatan | View Filing | |
| edgar index | S-8 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 20-F — Cellebrite DI Ltd. | View Filing | |
| edgar index | SCHEDULE 13G/A — Cellebrite DI Ltd. | View Filing | |
| edgar index | 144 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 144 — Cellebrite DI Ltd. | View Filing | |
| edgar index | 144 — Cellebrite DI Ltd. | View Filing |